SecBot SecBot
6-K ·Filed Nov 17, 2026
DA

DAVI

DAVION HEALTHCARE PLC
NEUTRAL
Impact 2/10
Horizonweeks Processed4d 16h ago SEC0001683168-26-008905
Notable filing: 6-K
Actionable Insight • Neutral

Monitor for any subsequent filings that disclose actual short interest levels, trading volume anomalies, or potential regulatory inquiries. The company's acknowledgment of short-selling activity may signal ongoing market concerns about share settlement and liquidity for this micro-cap issuer.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$1.03
T+0 close · Nov 17, 2026 · via day close
Latest settled
+3.88%
T+1 · $1.07
Vs SPY
+4.19%
α at T+1
Next horizon
T+5
tomorrow
  1. T+0 · Nov 17 $1.03entry
  2. T+1 · 4d ago +3.88%α +4.19% · $1.07
  3. T+3 · todayOpen
  4. T+5 · tomorrow Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Davion Healthcare issued a press release advising shareholders on how to use the Direct Registration System to independently confirm share ownership, in response to recent short-selling activity since its Nasdaq listing on October 22, 2026. The filing contains no financial results, guidance, or material corporate event, it is a procedural shareholder communication.

Key Facts

  • Davion Healthcare Plc (DAVI) issued a press release on November 17, 2026, providing guidance on direct registration and confirmation of share ownership.
  • The release was prompted by 'recent short-selling activity' since the company began trading on Nasdaq on October 22, 2026.
  • Shareholders may request electronic transfer of shares through the Direct Registration System (DRS) to VStock Transfer LLC for independent ownership confirmation.
  • The company explicitly states it is not alleging improper trading activity and is not recommending any action regarding buying, selling, or retaining shares.
  • No financial results, guidance, or material corporate events are reported in this filing.

Financial Impact

No financial impact stated; the filing is a procedural shareholder communication with no financial data.

Risk Factors

  • The filing acknowledges short-selling activity, which could indicate elevated volatility or liquidity concerns for a $25M market cap stock.
  • No financial data or operational updates are provided, limiting the filing's informational value for fundamental analysis.
  • The company's Nasdaq listing is less than one month old, making it difficult to assess normal trading patterns.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001683168-26-008905
Document: davion_6k.htm0001683168-26-008905
Document: 0001683168-26-008905-index-headers.html0001683168-26-008905
Document: 0001683168-26-008905-index.html0001683168-26-008905
Document: 0001683168-26-008905.txt0001683168-26-008905
Earnings Context (Synthetic; results releases only)0001683168-26-008905

US Market Status

Market Closed · Opens Mon (25h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 17, 2026